Jointly provided by Partners for Advancing Clinical Education and National Minority AIDS Council (NMAC)
The Biomedical HIV Prevention Summit 2026 (BHPS 2026) brings together healthcare providers, public health professionals, community leaders, researchers, and advocates committed to advancing HIV prevention across the United States. Centered on a syndemic approach, this year’s summit will explore how structural factors, social determinants of health, and interdisciplinary collaboration shape the future of HIV prevention and care.
Through expert-led sessions and collaborative dialogue, participants will examine emerging biomedical strategies, community-informed interventions, and innovative workforce models designed to strengthen HIV prevention efforts and improve health outcomes. The summit aims to equip attendees with practical tools, evidence-based insights, and cross-sector perspectives to support equitable and culturally responsive HIV prevention in clinical and community settings.
Target Audience
This activity is intended for physicians, pharmacists, nurse practitioners/physician assistants (NPs/PAs), nurses, other healthcare professionals (HCPs), and non-healthcare professionals who care for patients with HIV or are involved in HIV prevention, care, or public health programs.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Apply syndemic and systems-thinking frameworks to improve HIV prevention delivery in clinical and community settings
- Implement differentiated and culturally responsive biomedical HIV prevention strategies that address structural and social determinants of health
- Integrate interdisciplinary workforce models (e.g., pharmacists, CHWs, behavioral health professionals) into HIV prevention and care
- Translate emerging science, policy updates, and digital innovation into practical, scalable clinical and public health practice
Program Planning Committee
Meet our 2026 Biomedical HIV Prevention Summit committee members here
- Alison Footman, PhD — AIDS Vaccine Advocacy Coalition (AVAC)
- Anirudda Hazra, MD — University of Chicago
- Barbara Van Der Pol, PhD — University of Alabama
- Chase Cannon, MD — University of Washington
- Dr. Elijah Nicholas, DBA — National Trans Visibility March
- Gabriel Maldonado, MBA — TruEvolution
- Jonathan Colasanti, MD — Emory University
- June Gipson, PhD — My Brother’s Keeper Inc.
- Kenneth Mayer, MD — Fenway Institute
- LaRon E. Nelson, PhD — Yale University
- Leandro Mena, MD — National Minority AIDS Council (NMAC)
- Leisha McKinley-Beach, MPH — University of Florida
- Natalie Sánchez, MPH — Filmmaker and Podcaster
- Prescott Chow, MUP — Pacific AETC
- Richard Haverkate, MPH — Indian Health Service, DHHS
- Travis Gayle, MD — Howard Brown Health
- Vincent Guilamo-Ramos, PhD — Johns Hopkins University
- José M. Zuniga, PhD, MPH — International Association of Providers of AIDS Care (IAPAC) / Fast-Track Cities Institute
- Tamara McCants, PharmD — National Pharmaceutical Association
- Aliyah Ali, MPH — Courage Forward Strategies
Disclosures of Conflicts of Interest
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and National Minority AIDS Council (NMAC). Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 12.0 ANCC contact hours.
Pharmacy Continuing Education
Partners designates this continuing education activity for 12.0 contact hour(s) (0.9 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008073-9999-26-098-L02-P)
Type of Activity: Application
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Psychologist Continuing Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation
This program offers 12.0 continuing education credits for psychologists.
Social Work Continuing Education
As a Jointly Accredited Organization, Partners for Advancing Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 12.0 Partners for Advancing Clinical Education clinical to determine: Clinical continuing education credits.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 12.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions for Credit
To receive CE credit, learners must follow these steps:
- Visit https://cme.partnersed.com/2026Summit
- Complete the activity evaluation
- Upon completion of all evaluation questions, your credit will be made available for download immediately.
Contact
For information, updates, and questions about NMAC’s 2026 Biomedical HIV Prevention Summit, please email Conferences@NMAC.org